Tata Consumer Q3 Results: Tata Consumer Products is expected to post 15-17% revenue growth in Q3FY25, driven by strong domestic performance. However, rising tea prices may impact profitability, with brokerages predicting a YoY PAT decline. EBITDA margins are also expected to shrink.
Biocon buys back an investor stake in biologics unit, posts Rs 25 crore net profit in Q3FY25
Biocon’s board has approved the acquisition of 1.5% equity in Biocon Biologics for Rs 550 crore, increasing its stake to 90.2%. The deal is expected